Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003046 | Interleukin-12 in Treating Patients With Cancer in the Abdomen | completed | Phase 1 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00529984 | A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies(CEA(6D)VRP) | completed | Phase 1 / Phase 2 | 28 | AlphaVax, Inc.INDUSTRY | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00004910 | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00556023 | A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer | completed | Phase 1 | 37 | AstraZenecaINDUSTRY | 2 | Jun 6, 2012 | clinicaltrials |
| NCT00467116 | PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca | completed | Phase 1 | 9 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT01051284 | A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer | completed | Phase 1 | 14 | Georgetown UniversityOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00626158 | Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers | completed | Phase 1 | 45 | University of California, San FranciscoOTHER | 1 | Apr 4, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00547612 | Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer | completed | Phase 1 | 33 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00266097 | Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | completed | Phase 1 | 23 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 7, 2012 | clinicaltrials |
| NCT00034281 | Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 | completed | Phase 1 | 16 | TakedaINDUSTRY | 1 | Feb 2, 2012 | clinicaltrials |
| NCT00898287 | Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer(SAVIOR) | completed | Phase 1 / Phase 2 | 23 | Piramal Enterprises LimitedINDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer(CORGI) | completed | Phase 1 / Phase 2 | 106 | Lund University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00810953 | A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy | completed | Phase 1 / Phase 2 | 10 | Oncozyme Pharma Inc.INDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00004087 | Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer | completed | Phase 1 / Phase 2 | 15 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00504998 | Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer | completed | Phase 1 / Phase 2 | 20 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00003332 | Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer | completed | Phase 1 / Phase 2 | 36 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00242190 | Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer | completed | Phase 1 / Phase 2 | 40 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 15, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00648102 | Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer(CDX1307-02) | completed | Phase 1 | 36 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00709462 | A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) | completed | Phase 1 | 48 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00352131 | Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors | completed | Phase 1 | 50 | ImmunoGen, Inc.INDUSTRY | 1 | Mar 17, 2010 | clinicaltrials |
| NCT00316420 | Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer | completed | Phase 1 | 20 | Swedish Medical CenterOTHER | 1 | Mar 8, 2010 | clinicaltrials |
| NCT00744640 | Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma(GEMOXEL) | completed | Phase 1 / Phase 2 | 46 | University Hospital, Basel, SwitzerlandOTHER | 1 | Jan 12, 2010 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00220649 | Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas | completed | Phase 1 | 25 | St. Luke's-Roosevelt Hospital CenterOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00385177 | Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors | completed | Phase 1 | 61 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00288925 | Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment | completed | Phase 1 / Phase 2 | 30 | Zeria PharmaceuticalINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00102752 | Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer | completed | Phase 1 / Phase 2 | 47 | Threshold PharmaceuticalsINDUSTRY | 2 | Apr 30, 2009 | clinicaltrials |
| NCT00096707 | Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 50 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00234416 | IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 45 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00379132 | 131-I-TM-601 Study in Adults With Solid Tumors | completed | Phase 1 | 60 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00622622 | Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer | completed | Phase 1 | 21 | Wakayama Medical UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00252889 | Doxil Topotecan Doublet Cancer Study | completed | Phase 1 | 20 | Christiana Care Health ServicesOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00338026 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | completed | Phase 1 | 26 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00001431 | A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00041808 | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | completed | Phase 1 / Phase 2 | 20 | FeRxINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Jul 30, 2012source: clinicaltrials